Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05059951
Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer
Sponsor: Hunan Province Tumor Hospital
View on ClinicalTrials.gov
Summary
Although several clinical trials provide evidence for efficacy benefit for Checkpoint Inhibitors plus chemotherapy for lung cancer. However, there was rare evidence for clinical evidence in Hunan province.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
15000
Start Date
2021-10-03
Completion Date
2028-03-01
Last Updated
2024-06-04
Healthy Volunteers
Not specified
Conditions
Interventions
DRUG
Immune checkpoint inhibitor
Chemotherapy follow the guild line.
Locations (1)
Hunan Cancer Hospital
Changsha, Hunan, China